Navigation Links
Bristol-Myers Squibb Agrees to Clean Air Act Upgrades

CHICAGO, July 8 /PRNewswire-USNewswire/ -- Bristol-Myers Squibb, an international pharmaceutical manufacturer, has agreed to reduce the output of ozone-depleting refrigerants at multiple industrial facilities around the country at a combined cost of $3.65 million to resolve violations of the Clean Air Act, U.S. Environmental Protection Agency and U.S. Department of Justice announced today.

Under an agreement filed in federal court in Evansville, Ind., New York-based Bristol-Myers Squibb will be required to retire or retrofit 17 industrial refrigeration units by July 2009 at facilities in Mt. Vernon and Evansville, Ind.; Hopewell, N.J.; and Humacao and Mayaguez, Puerto Rico. The units are used in the facilities' industrial process or as air conditioners and currently use hydrochlorofluorocarbons, or HCFCs, as refrigerants.

When leaked into the air, HCFCs deplete ozone in the earth's stratosphere, which protects it from dangerous amounts of cancer-causing ultraviolet rays. Excessive UV exposure is linked to increased incidents of cataracts and poses risks to human immune systems and plant and animal life. The company has agreed to change over the 17 units to use only non ozone-depleting refrigerants.

In addition, the company has agreed to perform a supplemental environment project that will involve retiring two comfort cooling units at its New Brunswick, N.J., plant and connecting the air conditioners to the company's new centralized refrigeration system. The new system uses water-chilled coolers that act as the refrigerant to minimize the use of chemical agents in the chilling process.

Combined, the measures that the company is performing will remove more than 6,350 pounds of harmful HCFCs from their operations. Further, the company will take additional steps to assure compliance with EPA regulations at 13 of its facilities and pay $127,000 in civil penalties.

Following an EPA information request to ensure compliance with ozone-depletion regulations for the Evansville facility, Bristol-Myers Squibb voluntarily conducted an audit of 25 of its other facilities and reported all potential violations that were discovered. The audit uncovered potential violations at the 13 facilities located in six states -- Connecticut, Indiana, Massachusetts, Michigan, New Jersey, New York -- and in Puerto Rico.

"Bristol-Myers Squibb has acted responsibly, not only to discover, document and correct past violations, but to eliminate the use of potentially damaging refrigerants in its operations," said Granta Nakayama, assistant administrator for EPA's Office of Enforcement and Compliance Assurance. "These actions will help protect the ozone layer, ensuring a safer environment for our future generations."

"Bristol-Myers Squibb took action and reported Clean Air Act violations at multiple facilities and is now committed to removing thousands of pounds of harmful ozone-depleting refrigerants from its operations," said Ronald J. Tenpas, assistant attorney general for the Justice Department's Environmental and Natural Resources Division. "We are pleased that, after violating our ozone protection requirements, Bristol-Myers Squibb is now committed to a settlement that will be good for the environment and good business practice."

The proposed consent decree, lodged in the U.S. District Court for the Southern District of Indiana, is subject to a 30-day public comment period and approval by the federal court. Bristol-Myers Squibb is required to pay the penalty within 30 days of the court's approval of the settlement. A copy of the consent decree lodged today is available at the Department of Justice Web site at

More about EPA and ozone depletion is at bb-cd.pdf.

SOURCE U.S. Environmental Protection Agency Region 5
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Bristol-Myers Squibb Announces Dividend
2. Jeremy Levin Joins Bristol-Myers Squibb as Senior Vice President of External Science, Technology and Licensing
3. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
4. Bristol-Myers Squibb to Announce Results for the Third Quarter of 2007 on October 25
5. Pharmacopeia Acquires Selective Androgen Receptor Modulator (SARM) Program from Bristol-Myers Squibb
6. ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan
7. Exelixis to Receive Milestone Payment From Bristol-Myers Squibb for Achievement of Liver X Receptor Agonist Development Milestone
8. Bristol-Myers Squibb Names Alan J. Lacy to Board of Directors
9. Avista Capital Partners Completes Acquisition of Bristol-Myers Squibb Medical Imaging
10. Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007
11. Bristol-Myers Squibb to Present at Healthcare Conferences
Post Your Comments:
(Date:11/26/2015)... ... 26, 2015 , ... Somu Sivaramakrishnan announced today that he ... now offers travelers, value and care based Travel Services, including exclusive pricing on ... as, cabin upgrades and special amenities such as, shore excursions, discounted fares, travel ...
(Date:11/26/2015)... ... , ... PRMA Plastic Surgery is updating their record books yet again with ... flap breast reconstruction surgery! , “What an accomplishment for the PRMA team, says ... it’s an honor to have served all of these women.” , PRMA is one ...
(Date:11/26/2015)... Karnataka (PRWEB) , ... November ... ... innovative online platform for mental health and wellness consultation, has collaborated with ... to holistically address their reader’s queries on topics on mental and emotional ...
(Date:11/25/2015)... Indianapolis, IN (PRWEB) , ... November 25, 2015 ... ... clean water accessible for all, Water For Empowerment ™ attracts volunteers together ... on clean water by empowering women as key stakeholders in the process. The ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... recognized once again for its stellar workplace culture with the company’s Cincinnati office ... , Medical Solutions’ Cincinnati office was named a finalist in Cincinnati Business Courier’s ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 Research and Markets ( ) ... Pacemaker Market Outlook to 2019 - Rise in Cardiac Disorders ... report to their offering. Boston ... Boston scientific and others. --> ... Biotronik, Boston scientific and others. ...
(Date:11/26/2015)... November 26, 2015 ... the "2016 Future Horizons and Growth ... Testing Market: Supplier Shares, Country Segment Forecasts, ... their offering. --> ) ... "2016 Future Horizons and Growth Strategies in ...
(Date:11/26/2015)... November 26, 2015 ... "Self Administration of High Viscosity Drugs" report ... has announced the addition of the "Self ... their offering. --> Research and Markets ... the "Self Administration of High Viscosity Drugs" ...
Breaking Medicine Technology: